Herbert Virgin, EVP, Research & CSO at Vir Biotechnology, Inc. (VIR), sold 2,750 shares at $45.03 ($124K) on 2021-05-18, disclosed to the SEC on 2021-05-19.
Open-market sale of $124k VIR by EVP, Research & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.03 | 1,375 | $62K | 50.0% |
| 2 | $45.03 | 1,375 | $62K | 50.0% |
| Total | $45.03 avg | 2,750 | $124K | 100% |
| Filing → |
| VIR | SELL | 2022-02-09 | $47K | — | Filing → |
| VIR | SELL | 2022-01-26 | $45K | — | Filing → |
| VIR | SELL | 2022-01-13 | $48K | — | Filing → |